Sign Out
Levacore is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Levacore is indicated as adjunctive therapy: in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
In the treatment of primary generalised tonic clonic seizures in adults, adolescents and children from 6 years of age with Idiopathic Generalised Epilepsy.
Levacore concentrate is an alternative for patients when oral administration is temporarily not feasible.
